NYSE: TRXC - TransEnterix

Yield per half year: 0%
Sector: Healthcare

TransEnterix

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 57.86 -100% 0 0%
P/S 332.81 4.07 8081.87%
P/BV 6.56 9.4 -30.18%
P/FCF 0 46.57 -100%
Ev/Ebitda -7.24 17.55 -141.25%
Ev/S -4.4 4.37 -200.77%
Ev/FCF 0.2998 54.59 -99.45%
E/P 0 0.2164 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
0 20.15 -100% -1310.86 -100%
ROE -94.1 -80.86 16.38%
ROA -44.58 6.71 -763.97%
ROIC 0 15.68 -100%
ROS -1864.78 10.55 -17767.27%
ROCE 0 18.05 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.0599 2.82 -102.13% -0.0509 +17.53%
Nеt Debt/Ebitda 0.2866 3.64 -92.12%
Debt/Ratio 0.036 0.261 -86.2%
Debt/Equity 0.0458 4.49 -98.98%
Debt/Net Income -0.0476 6.45 -100.74%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.29 -100% 0 0%
Number of years of dividend growth 0 6.33 -100%
DSI 0 0.7376 -100%
Average dividend growth 0 -3.12 -100%
Average percentage for 5 years 0 1.29 -100%
Average percentage for payments 0 77.61 -100%
Difference from average difference in sector -1.29

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-33.8 362.86 -109.31%
Growth impulse Ebitda in 5 years -6.15 373.75 -101.65%
Growth impulse Net Income in 5 years -58.49 454.84 -112.86%
Growth impulse FCF in 5 years -13.04 306.17 -104.26%
Growth impulse EPS in 5 years -97.96 455.99 -121.48%
IP Score
2.55/10

Similar companies

Varian Medical

Boston Scientific

Allergan

Laboratory Corporation of America Holdings

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription